Pliant Therapeutics (PLRX)
(Real Time Quote from BATS)
$12.37 USD
+0.20 (1.64%)
Updated May 31, 2024 11:36 AM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Earnings News For PLRX
-
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
-
Earnings Preview: Pliant Therapeutics, Inc. (PLRX) Q4 Earnings Expected to Decline
-
Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2023 Financial Results
-
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
-
Pliant Therapeutics, Inc. (PLRX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
-
Pliant Therapeutics, Inc. (PLRX) Reports Q2 Loss, Misses Revenue Estimates
-
Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results
-
Pliant Therapeutics, Inc. (PLRX) Reports Q1 Loss, Misses Revenue Estimates
-
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
-
Pliant Therapeutics, Inc. (PLRX) Reports Q4 Loss, Tops Revenue Estimates
-
Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2022 Financial Results
-
Pliant Therapeutics, Inc. (PLRX) Reports Q3 Loss, Misses Revenue Estimates
-
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results
-
Pliant Therapeutics, Inc. (PLRX) Reports Q2 Loss, Tops Revenue Estimates
-
Pliant Therapeutics, Inc. (PLRX) Expected to Beat Earnings Estimates: Should You Buy?
-
Pliant Therapeutics, Inc. (PLRX) Reports Q1 Loss, Lags Revenue Estimates
-
Pliant Therapeutics, Inc. (PLRX) Reports Q4 Loss, Lags Revenue Estimates
-
Pliant Therapeutics, Inc. (PLRX) Reports Q3 Loss, Misses Revenue Estimates